ERalpha degrader7 (Compound B1) is a potent ERalpha degrader, exhibiting an IC50 of 14.6 nM and a DC50 of 9.7 nM. This compound demonstrates excellent antitumor activity, indicating its potential as a selective estrogen receptor degrader (SERD) for breast cancer research.
Formula:
C28H24F4N2O3
Target:
Estrogen Receptor/ERR
* VAT and and shipping costs not included. Errors and price changes excepted
